Spots Global Cancer Trial Database for Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
Official Title: Phase IB Study of Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
Study ID: NCT03719768
Study Description
Brief Summary: This study is to find a safe dose of the combination of Avelumab and Whole Brain Radiotherapy (WBRT) in patients with Leptomeningeal Disease.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Contact Details
Name: Peter A Forsyth, MD
Affiliation: H. Lee Moffitt Cancer Center and Research Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
